Product Details

Adapalene + Benzoyl Peroxide 0.1% + 2.5% Cream/Ointment delivers a high-quality topical combination therapy formulated to British Pharmacopoeia (BP) and Indian Pharmacopoeia (IP) standards. This fixed-dose combination manages acne vulgaris, combining retinoid-based comedolytic action with antibacterial and keratolytic effects in a single topical preparation.

The cream/ointment combines:

• Adapalene, a third-generation topical retinoid that normalizes skin cell turnover and clears clogged pores by binding to retinoic acid receptors, reducing comedone formation, and
• Benzoyl Peroxide, a keratolytic and antibacterial agent that reduces acne-causing bacteria and clears clogged pores by releasing oxygen free radicals that damage bacterial cell walls.

Doctors commonly prescribe this combination for the treatment of acne vulgaris, particularly in cases involving both comedonal and inflammatory lesions. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP/IP-standard compliant topical combination therapy
• Treats acne vulgaris across comedonal and inflammatory lesions
• Delivers combined retinoid and antibacterial keratolytic action
• Contains Adapalene 0.1% + Benzoyl Peroxide 2.5%
• Maintains a high-purity, stable formulation
• Convenient 15 g tube for topical application
• Suits hospital, clinical, and pharmacy use